Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025. This prestigious event brought together global experts to discuss the latest advancements in atherosclerosis and vascular disease research.

We firmly believe that close collaboration with scientific experts and clinicians is essential for proposing treatments with added value to the people who depend on them every day. That is why we have become an official partner of the EAS for the second consecutive year. Through our partnership with the European Atherosclerosis Society, we support scientific leadership via the publication of guidelines and consensus position papers, fostering discussions on new developments in the field of atherosclerosis. This collaboration helps us fulfill our purpose of providing health and wellbeing for all generations.

For more information about the EAS Congress 2025, please visit the official website here.